Publication | Closed Access

Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate

InflammationThrombosisMetabolic SyndromeVascular DiseaseCardiovascular DiseasePharmacologyEndothelial DysfunctionPathologyHyperlipidemiaVascular BiologyReceptor Flt-1Vascular Endothelial Growth FactorMedicineAtherosclerosisDyslipidemiaHealth Sciences